Approvals/TGA/PRALUENT alirocumab 150mg/mL, solution for injection, pre-filled syringe

Approved

STANDARD

PRALUENT alirocumab 150mg/mL, solution for injection, pre-filled syringe

Sanofi-Aventis Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 9de48d9634439a2d
Product Name: PRALUENT alirocumab 150mg/mL, solution for injection, pre-filled syringe
Artg Id: 238305
Artg Name: PRALUENT alirocumab (rch) 150mg/mL solution for injection pre-filled syringe
Sponsor: Sanofi-Aventis Australia Pty Ltd
Company Detail Path: /organization/sanofi-aventis-australia-pty-ltd
Artg Date: 2016-05-17
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2016-CMI-01965-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2015-PI-01366-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

9de48d9634439a2d

Type

Standard